Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
1 participants
INTERVENTIONAL
2024-01-12
2029-01-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The topic is of an applied nature and is aimed at improving the results of comprehensive treatment of patients with COVID-19, the course of whose disease was complicated by thrombotic or hemorrhagic catastrophes.
It is planned to analyze the results of treatment of this category of patients based on the work of several centers that provided surgical care to patients with COVID-19 during the pandemic (8 cities).
As a result of the analysis, it is planned to develop algorithms for the prevention and treatment of thrombotic and hemorrhagic complications in patients with COVID-19.
The proposed study will be multicenter, cohort, retrospective.
The purpose of the study:
Improvement of treatment results in COVID-19 patients with thrombotic or hemorrhagic complications
Scientific novelty:
For the first time, as a result of a multicenter study, it is expected to identify the most effective approach to the treatment and prevention of thrombotic and hemorrhagic complications in patients with COVID-19.
For the first time, it is planned to develop and put into practice algorithms for the application of the most effective methods of treatment and prevention of thrombohemorrhagic complications of COVID-19.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence, Predictors and Validation of Risk Scores to Predict Myocardial Infarction After Noncardiac Vascular Surgery
NCT04051749
Sevoflurane and Hyperperfusion Syndrome
NCT02510586
Cardiovascular Outcomes and Mortality in Vascular Surgical Patients
NCT05208957
Outcomes of Vascular Surgery in COVID-19 Infection: National Cohort Study
NCT04333693
Evaluation of BIomarkers for POstoperative Complications in Non-cardiac Surgery Patients
NCT03765372
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Thrombotic and hemorrhagic complications of COVID-19
Prevention algorithm
Development of an algorithm for the prevention of thrombohemorrhagic complications
Prevention of thrombohemorrhagic complications in COVID-19
Prevention algorithm
Development of an algorithm for the prevention of thrombohemorrhagic complications
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prevention algorithm
Development of an algorithm for the prevention of thrombohemorrhagic complications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who had thrombohemorrhagic disorders before admission to the hospital
* Pregnant women
* Patients receiving routine anticoagulant and antiplatelet therapy before admission to the hospital
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Volgograd State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Viktor Mikhin
Role: STUDY_CHAIR
Volgograd State Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic №1 of Volgograd State Medical University
Volgograd, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12/2024/01/12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.